| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 20 |
| 1 | POLYETHYLENE GLYCOL 3350 | 17 |
| 2 | INSTALAX POLYETHYLENE GLYCOL 3350 | 15 |
| 3 | POLYETHYLENE GLYCOL (3350) | 15 |
| 4 | POLYETHYLENE GLYCOL 400 | 15 |
| 5 | ALBUTEROL SULFATE | 10 |
| 6 | DUPILUMAB | 8 |
| 7 | ALBUTEROL | 7 |
| 8 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 6 |
| 9 | ACETYLCYSTEINE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INSTALAX POLYETHYLENE GLYCOL 3350 | 15 | 0.0012 |
| 1 | POLYETHYLENE GLYCOL 400 | 15 | 0.0012 |
| 2 | MIGLITOL | 1 | 0.0010 |
| 3 | VERICIGUAT | 1 | 0.0010 |
| 4 | EPINASTINE HYDROCHLORIDE | 1 | 0.0009 |
| 5 | SODIUM SULFATE, MAGNESIUM SULFATE, AND POTASSIUM CHLORIDE | 1 | 0.0006 |
| 6 | NALDEMEDINE | 1 | 0.0006 |
| 7 | ACETYLCYSTEINE | 5 | 0.0005 |
| 8 | DOXYLAMINE SUCCINATE | 3 | 0.0005 |
| 9 | STIRIPENTOL | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 28 |
| 1 | Osmotic Laxative [EPC] | 18 |
| 2 | Interleukin-4 Receptor alpha Antagonist [EPC] | 8 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 8 |
| 4 | Corticosteroid [EPC] | 7 |
| 5 | Mood Stabilizer [EPC] | 6 |
| 6 | Anti-epileptic Agent [EPC] | 5 |
| 7 | Antidote [EPC] | 5 |
| 8 | Antidote for Acetaminophen Overdose [EPC] | 5 |
| 9 | Estrogen [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Erythroid Maturation Agent [EPC] | 1 | 0.0004 |
| 1 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 5 | 0.0002 |
| 2 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 3 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 4 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 5 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 6 | Antidote [EPC] | 5 | 0.0001 |
| 7 | Melatonin Receptor Agonist [EPC] | 1 | 0.0001 |
| 8 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 9 | Atypical Antipsychotic [EPC] | 28 | 0.0001 |